Literature DB >> 35291203

Proposal of new treatment algorithm for gastric cancer liver metastases: Up-front surgery or conversion surgery?

Nobuyuki Takemura1, Akio Saiura2, Hiromichi Ito3, Kyoji Ito1, Fuyuki Inagaki1, Fuminori Mihara1, Shusuke Yagi4, Naoki Enomoto4, Kyoko Nohara4, Yosuke Inoue3, Yu Takahashi3, Kazuhiko Yamada4, Norihiro Kokudo1.   

Abstract

Hepatectomy for gastric cancer liver metastases (GCLM) has a 5-year survival rate of 9-42%; however, indications for hepatectomy remain unclear. Many researchers have reported prognostic factors for GCLM after hepatectomy, but surgical indications vary according to the literature. Furthermore, the indication for optimal candidates for neoadjuvant chemotherapy and intensive chemotherapy is also unclear. To understand the indications for surgery and chemotherapy intended for hepatectomy for GCLM, a new treatment algorithm was created based on previously reported evidence from the viewpoint of hepatic surgeons. 2022, National Center for Global Health and Medicine.

Entities:  

Keywords:  conversion surgery; gastric cancer liver metastases; treatment algorithm; up-front surgery

Year:  2022        PMID： 35291203      PMCID： PMC8884038          DOI： 10.35772/ghm.2021.01102

Source DB:  PubMed          Journal:  Glob Health Med        ISSN： 2434-9186


  19 in total

1.  Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.

Authors:  Minoru Fukuchi; Toru Ishiguro; Kyoichi Ogata; Okihide Suzuki; Youichi Kumagai; Keiichiro Ishibashi; Hideyuki Ishida; Hiroyuki Kuwano; Erito Mochiki
Journal:  Ann Surg Oncol       Date:  2015-02-07       Impact factor: 5.344

2.  Outcomes of 1,639 hepatectomies for non-colorectal non-neuroendocrine liver metastases: a multicenter analysis.

Authors:  Keiji Sano; Masakazu Yamamoto; Tetsushige Mimura; Itaru Endo; Shoji Nakamori; Masaru Konishi; Masaru Miyazaki; Toshifumi Wakai; Masato Nagino; Keiichi Kubota; Michiaki Unno; Naohiro Sata; Junji Yamamoto; Hiroki Yamaue; Tadahiro Takada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2018-11-20       Impact factor: 7.027

3.  A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma.

Authors:  H Imamura; Y Matsuyama; R Shimada; M Kubota; A Nakayama; A Kobayashi; H Kitamura; T Ikegami; S I Miyagawa; S Kawasaki
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

4.  Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections.

Authors:  Nobuyuki Takemura; Akio Saiura; Rintaro Koga; Junichi Arita; Ryuji Yoshioka; Yoshihiro Ono; Naoki Hiki; Takeshi Sano; Junji Yamamoto; Norihiro Kokudo; Toshiharu Yamaguchi
Journal:  Langenbecks Arch Surg       Date:  2012-05-22       Impact factor: 3.445

5.  Clinical benefit of surgical management for gastric cancer with synchronous liver metastasis.

Authors:  Masaki Aizawa; Atsushi Nashimoto; Hiroshi Yabusaki; Satoru Nakagawa; Atsushi Matsuki
Journal:  Hepatogastroenterology       Date:  2014 Jul-Aug

6.  Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England.

Authors:  Sheraz R Markar; Hugh Mackenzie; Sameh Mikhail; Muntzer Mughal; Shaun R Preston; Nick D Maynard; Omar Faiz; George B Hanna
Journal:  Gastric Cancer       Date:  2016-03-03       Impact factor: 7.370

7.  Therapeutic significance of noncurative gastrectomy for gastric cancer with liver metastasis.

Authors:  S Koga; H Kawaguchi; H Kishimoto; K Tanaka; Y Miyano; O Kimura; R Takeda; H Nishidoi
Journal:  Am J Surg       Date:  1980-09       Impact factor: 2.565

8.  Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302).

Authors:  Eiji Oki; Shoji Tokunaga; Yasunori Emi; Tetsuya Kusumoto; Manabu Yamamoto; Kengo Fukuzawa; Ikuo Takahashi; Sumiya Ishigami; Akihito Tsuji; Hidefumi Higashi; Toshihiko Nakamura; Hiroshi Saeki; Ken Shirabe; Yoshihiro Kakeji; Kenji Sakai; Hideo Baba; Tadashi Nishimaki; Shoji Natsugoe; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2015-08-11       Impact factor: 7.370

9.  The long-term survival of stage IV gastric cancer patients with conversion therapy.

Authors:  Kazuya Yamaguchi; Kazuhiro Yoshida; Toshiyuki Tanahashi; Takao Takahashi; Nobuhisa Matsuhashi; Yoshihiro Tanaka; Kazuaki Tanabe; Hideki Ohdan
Journal:  Gastric Cancer       Date:  2017-06-14       Impact factor: 7.370

Review 10.  Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification.

Authors:  Kazuhiro Yoshida; Kazuya Yamaguchi; Naoki Okumura; Toshiyuki Tanahashi; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2015-12-07       Impact factor: 7.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.